{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:14:57Z","timestamp":1791152097730,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":5504,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1093\/annonc\/mdh465","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T19:33:12Z","timestamp":1100806392000},"page":"1798-1804","source":"Crossref","is-referenced-by-count":64,"title":["Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study"],"prefix":"10.1016","volume":"15","author":[{"given":"A.","family":"Rueda Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gum\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Llanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"de las Nieves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Miram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdh465_bb0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0140-6736(03)12777-8","article-title":"Hodgkin's lymphoma","volume":"361","author":"Yung","year":"2003","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdh465_bb0015","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"van den Belt-Dusebout AW, Klokman WJ et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0020","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","article-title":"Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease","volume":"94","author":"Travis","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdh465_bb0030","series-title":"Hodgkin\u2019s Disease","first-page":"607","article-title":"Second cancers after treatment of Hodgkin\u2019s disease","author":"van Leeuwen","year":"1999"},{"key":"10.1093\/annonc\/mdh465_bb0035","series-title":"Hodgkin\u2019s Disease","first-page":"647","article-title":"Cardiovascular late effects after treatment of Hodgkin\u2019s disease","author":"Hancock","year":"1999"},{"key":"10.1093\/annonc\/mdh465_bb0040","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin's disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdh465_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0050","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0055","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1200\/JCO.1991.9.6.906","article-title":"Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial","volume":"9","author":"Longo","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0060","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.1992.10.3.378","article-title":"Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of patologic stage I\u2013IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study","volume":"10","author":"Biti","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0065","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM200205023461821","article-title":"Long-term follow-up of Hodgkin's disease trial","volume":"346","author":"Canellos","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdh465_bb0070","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.2003.12.086","article-title":"Randomized comparison of ABVD and MOPP\/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial","volume":"21","author":"Duggan","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0075","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0277-5379(85)90088-4","article-title":"Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD","volume":"21","author":"Viviani","year":"1985","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0080","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V59.3.488.488","article-title":"Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease","volume":"59","author":"Valagussa","year":"1982","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh465_bb0085","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1200\/JCO.1997.15.3.1118","article-title":"Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study","volume":"15","author":"Rueda","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0090","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/10428190109057990","article-title":"Secondary prophylactic G-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD","volume":"41","author":"Rueda","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh465_bb0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdh465_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observation","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdh465_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdh465_bb0115","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1200\/JCO.1993.11.11.2258","article-title":"Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group","volume":"11","author":"Carde","year":"1993","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdh465_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/annonc\/13.S1.1","article-title":"An overview of the Fifth International Symposium on Hodgkin's lymphoma: recent advances in basic and clinical research","volume":"13","author":"Wiedenmann","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.683","article-title":"Approach to Hodgkin's lymphoma in the new millennium","volume":"20","author":"Fung","year":"2002","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0360-3016(94)90222-4","article-title":"Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution","volume":"29","author":"Biti","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdh465_bb0135","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin's disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors","volume":"15","author":"Ng","year":"2002","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh465_bb0140","first-page":"65","article-title":"Late morbidity and survival in early stage Hodgkin's disease treated with involved field or wide field radiotherapy alone","volume":"13","author":"Hoskin","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdh465_bb0150","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdh465_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mpo.1122","article-title":"Radiation and breast carcinogenesis","volume":"36","author":"Boice","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0160","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jnci\/95.13.928","article-title":"Radiation therapy in the treatment of Hodgkin's disease\u2014do you see what I see?","volume":"95","author":"Longo","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdh465_bb0165","first-page":"54","article-title":"The EORTC treatment strategy in Hodgkin's lymphoma (HL): A 4-decade experience","volume":"42","author":"Henry-Amar","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh465_bb0170","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"Engert","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0175","first-page":"12","volume":"42","author":"Meerwaldt","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh465_bb0180","first-page":"769a","article-title":"Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD\u2009+\u2009radiation therapy for early stage non-bulky Hodgkin's disease","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh465_bb0185","first-page":"81a","volume":"102","author":"Meyer","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdh465_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/1042819021000035635","article-title":"The management of stage I\u2013II supradiaphragmatic Hodgkin's disease with chemotherapy alone","volume":"44","author":"Provencio","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdh465_bb0195","first-page":"38","article-title":"ABVD in the treatment of Hodgkin's disease","volume":"19","author":"Bonfante","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0200","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1200\/JCO.1996.14.5.1421","article-title":"Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results","volume":"14","author":"Viviani","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/mpo.2950240604","article-title":"Cardiac failure and dysrhythmias 6\u201319 years after anthracycline therapy: a series of 15 patients","volume":"24","author":"Steinherz","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"10.1093\/annonc\/mdh465_bb0210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.1989.7.3.387","article-title":"Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol","volume":"7","author":"Einhorn","year":"1989","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419609014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419609014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/15\/12\/1798\/830048\/mdh465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:06:56Z","timestamp":1582247216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419609014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0923753419609014"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdh465","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}